Mark Kidd Selected Research

Carcinoid Tumor (Carcinoid)

1/2020	An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis.
1/2018	The utility of blood neuroendocrine gene transcript measurement in the diagnosis of bronchopulmonary neuroendocrine tumours and as a tool to evaluate surgical resection and disease progression.
11/2017	Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasms.
11/2017	The role of peptide receptor radionuclide therapy in advanced/metastatic thoracic neuroendocrine tumors.
12/2014	A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors.
8/2014	A historical appreciation of bronchopulmonary neuroendocrine neoplasia: resolution of a carcinoid conundrum.
7/2013	Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors.
2/2013	Systemic therapeutic options for carcinoid.
1/2013	Immunohistochemical evidence for an impairment of autophagy in tumorigenesis of gastric carcinoids and adenocarcinomas in rodent models and patients.
6/2012	Ultrastructure of ECL cells in Mastomys after long-term treatment with H2 receptor antagonist loxtidine.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark Kidd Research Topics

Disease

56	Neoplasms (Cancer) 10/2021 - 01/2005
36	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2021 - 02/2006
30	Carcinoid Tumor (Carcinoid) 01/2020 - 01/2002
20	Neoplasm Metastasis (Metastasis) 10/2016 - 05/2005
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2015 - 07/2002
4	Adenocarcinoma 06/2013 - 02/2006
4	Fibrosis (Cirrhosis) 06/2010 - 01/2003
3	Abdominal Pain (Pain, Abdominal) 01/2016 - 02/2007
3	Colorectal Neoplasms (Colorectal Cancer) 07/2006 - 01/2005
3	Gastroesophageal Reflux (GERD) 05/2004 - 01/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020 - 07/2008
2	Carcinoma (Carcinomatosis) 01/2020 - 07/2008
2	Neoplasm Micrometastasis 01/2019 - 02/2006
2	Carcinogenesis 01/2019 - 06/2012
2	Lymphatic Metastasis 07/2018 - 06/2012
2	Heart Diseases (Heart Disease) 02/2016 - 12/2004
2	Hyperplasia 04/2015 - 06/2012
2	Colitis 01/2015 - 01/2013
2	Hypoxia (Hypoxemia) 01/2013 - 11/2012
2	Confusion (Bewilderment) 02/2011 - 01/2011
2	Carcinoid Heart Disease 01/2010 - 12/2004
2	Melanoma (Melanoma, Malignant) 04/2009 - 02/2006
2	Diarrhea 02/2007 - 05/2005
2	Flushing 05/2005 - 12/2004
2	Stomach Neoplasms (Stomach Cancer) 08/2004 - 01/2002
1	Lung Diseases (Lung Disease) 01/2020
1	Disease Progression 01/2020
1	Residual Neoplasm 01/2019
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2017
1	Gastro-enteropancreatic neuroendocrine tumor 09/2016
1	Circulating Neoplastic Cells 01/2016
1	Glucagonoma 04/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015
1	Crohn Disease (Crohn's Disease) 01/2015
1	Ulcerative Colitis 01/2015
1	Pain (Aches) 01/2015

Drug/Important Bio-Agent (IBA)

20	Chromogranin AIBA 01/2020 - 02/2006
18	Biomarkers (Surrogate Marker)IBA 03/2020 - 03/2010
17	Biological ProductsIBA 01/2018 - 01/2002
12	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 01/2008
11	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2005
10	Messenger RNA (mRNA)IBA 11/2021 - 02/2006
9	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 12/2004
9	Peptide Receptors (Peptide Receptor)IBA 11/2017 - 03/2008
7	Radioisotopes (Radionuclides)IBA 11/2017 - 08/2014
7	GastrinsIBA 01/2016 - 08/2003
7	AcidsIBA 01/2015 - 08/2003
4	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2017 - 12/2011
4	Peptides (Polypeptides)IBA 08/2014 - 05/2005
4	AminesIBA 07/2013 - 05/2005
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 06/2010
3	Pharmaceutical PreparationsIBA 01/2018 - 01/2011
3	TOR Serine-Threonine KinasesIBA 01/2014 - 01/2011
3	Phosphotransferases (Kinase)IBA 01/2013 - 03/2011
2	Tumor Biomarkers (Tumor Markers)IBA 01/2020 - 03/2011
2	pancreastatinIBA 01/2019 - 08/2014
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2016
2	ChromatinIBA 11/2017 - 01/2014
2	uroguanylinIBA 01/2016 - 01/2015
2	guanylinIBA 01/2016 - 01/2015
2	Insulin (Novolin)FDA Link 01/2016 - 01/2014
2	ChromograninsIBA 04/2015 - 07/2014
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 07/2014
2	Proton Pump InhibitorsIBA 12/2014 - 03/2004
2	Insulin-Like Growth Factor I (IGF-1)IBA 07/2013 - 03/2011
2	Oxygen (Dioxygen)IBA 01/2013 - 11/2012
2	Renilla LuciferasesIBA 01/2013 - 11/2012
2	loxtidineIBA 01/2013 - 06/2012
2	SynaptophysinIBA 12/2011 - 07/2010
2	MTOR InhibitorsIBA 09/2011 - 01/2011
2	Tyrosine (L-Tyrosine)FDA Link 03/2011 - 08/2004
2	Hormones (Hormone)IBA 04/2009 - 02/2009
2	AntigensIBA 04/2009 - 02/2006
2	Antineoplastic Agents (Antineoplastics)IBA 08/2008 - 03/2008
2	Cadherins (E-Cadherin)IBA 06/2007 - 02/2007
2	Estrogens (Estrogen)FDA Link 07/2006 - 02/2006
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2006 - 02/2006
2	Histamine (Histamine Dihydrochloride)FDA Link 03/2004 - 01/2004
1	N 30IBA 10/2021
1	entinostat (MS 275)IBA 01/2018
1	Everolimus FDA Link 11/2017
1	Hydroxyindoleacetic AcidIBA 11/2017
1	177Lu-octreotateIBA 11/2017
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2017
1	Alkylating AgentsIBA 01/2016
1	Glucagon Receptors (Glucagon Receptor)IBA 04/2015
1	Glucagon (Glukagon)FDA Link 04/2015
1	antineoplaston A10 (A 10)IBA 04/2015
1	LigandsIBA 01/2015
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2015
1	sym-trinitrobenzeneIBA 01/2015
1	StathminIBA 01/2015
1	Neurokinin AIBA 08/2014

Therapy/Procedure

24	Therapeutics 11/2017 - 01/2004
3	Drug Therapy (Chemotherapy) 11/2017 - 02/2013
2	Precision Medicine 01/2021 - 01/2015
2	Biological Therapy 11/2017 - 01/2008
2	Microspheres (Microsphere) 07/2012 - 05/2006
2	Radiofrequency Ablation 05/2006 - 05/2005
2	Fundoplication 03/2004 - 01/2004